HRT receives a $3.42M grant from Purdue Pharma

Harm Reduction Therapeutics’ work to develop and sell a low cost, over-the-counter naloxone nasal spray is now rapidly moving forward thanks to a $3.42M grant from Purdue Pharma L.P. We are a nonprofit pharmaceutical company working to break down price and access barriers by bringing naloxone over-the-counter (OTC) at the lowest possible price. These funds are an important step towards our goal of making low cost OTC naloxone as widely available as possible.

https://www.businesswire.com/news/home/20180905005163/en/Purdue-Pharma-L.P.-Fund-Harm-Reduction-Therapeutics

Michael Hufford